Eventide Asset Management’s Nurix Therapeutics NRIX Stock Holding History

Eventide Asset Management’s Portfolio NRIX Stock Details NRIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$24.6M	Buy
2022 Q3	–	Sell
2022 Q2	$14.6M	Sell
2022 Q1	$26.2M	Hold
2021 Q4	$54.1M	Buy
2021 Q3	$36M	Hold
2021 Q2	$31.8M	Hold
2021 Q1	$37.3M	Buy
2020 Q4	$34.5M	Buy
2020 Q3	$17.4M	Buy